Takeda Continues Divestiture Strategy with Sale of Select OTC and Non-Core Assets in Europe to Orifarm for up to approximately $670M USD Read more
Affinivax Announces $120 Million Series B Financing to Advance Pipeline of Novel MAPS Vaccines and Immunotherapies Read more
Catalent Biologics Completes $14 Million Commercial Packaging Expansion at its Bloomington, Indiana Facility Read more
Novartis announces data showing Jakavi more effective than best available therapy in acute GvHD Read more
Novartis Kymriah receives FDA Regenerative Medicine Advanced Therapy designation in follicular lymphoma Read more